Related Experiment Video
Updated: Feb 24, 2026
06:18
Multiplexed Isothermal Amplification Based Diagnostic Platform to Detect Zika, Chikungunya, and Dengue 1
Published on: March 13, 2018
14.9K
Point-of-Care Molecular Test for Zika Infection
Michael G Mauk1, Jinzhao Song1, Haim H Bau1
1Department of Mechanical Engineering and Applied Mechanics, School of Engineering and Applied Science, University of Pennsylvania, Philadelphia PA.
Clinical Laboratory International
|August 19, 2017
Summary
A new Zika virus (ZIKV) diagnostic test offers rapid, sensitive, and affordable detection in saliva. This point-of-care technology uses a self-heating cup for isothermal amplification, enabling easy visual results without electricity.
Area of Science:
- Virology
- Public Health
- Biotechnology
Background:
- The Zika virus (ZIKV) outbreak poses a significant public health risk.
- ZIKV infection is often asymptomatic but can cause severe congenital abnormalities.
- There is a critical need for rapid, sensitive, and accessible diagnostic tools for ZIKV.
Purpose of the Study:
- To develop a simple, sensitive, and inexpensive point-of-care (POC) diagnostic technology for ZIKV detection.
- To enable rapid ZIKV diagnosis directly from saliva samples.
- To provide a visually readable detection method.
Main Methods:
- Utilized a chemically heated cup for isothermal amplification, eliminating the need for electrical power.
- Developed a diagnostic assay for ZIKV detection in saliva.
- Implemented a visual readout system for straightforward result interpretation.
Main Results:
- Demonstrated a simple, sensitive, and inexpensive POC diagnostic technology for ZIKV.
- Achieved rapid detection of ZIKV in saliva samples.
- The assay provided results that could be directly read by eye.
Conclusions:
- The developed POC diagnostic technology is a promising tool for rapid ZIKV detection.
- This technology can be deployed in resource-limited settings due to its simplicity and lack of power requirement.
- The visual readout facilitates widespread use in point-of-care scenarios for ZIKV surveillance and management.
